title: Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family.
abstract: Inhibitor of apoptosis protein (IAP)-like protein-1 (ILP-1) (also known as X-linked IAP [XIAP] and mammalian IAP homolog A [MIHA]) is a potent inhibitor of apoptosis and exerts its effects, at least in part, by the direct association with and inhibition of specific caspases. Here, we describe the molecular cloning and characterization of a human gene related to ILP-1, termed ILP-2. Despite high homology to ILP-1, ILP-2 is encoded by a distinct gene, which in normal tissues is expressed solely in testis. In contrast to ILP-1, overexpression of ILP-2 had no protective effect on apoptosis mediated by Fas (also known as CD95) or tumor necrosis factor. However, ILP-2 potently inhibited apoptosis induced by overexpression of Bax or by coexpression of caspase 9 with Apaf-1, and preincubation of cytosolic extracts with ILP-2 abrogated caspase activation in vitro. A processed form of caspase 9 could be coprecipitated with ILP-2 from cells, suggesting a physical interaction between ILP-2 and caspase 9. Thus, ILP-2 is a novel IAP family member with restricted specificity for caspase 9.
authors.affiliation: Metabolism Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1578, USA.
authors.forename: B W
authors.initials: BW
authors.lastname: Richter
authors.forename: S S
authors.initials: SS
authors.lastname: Mir
authors.forename: L J
authors.initials: LJ
authors.lastname: Eiben
authors.forename: J
authors.initials: J
authors.lastname: Lewis
authors.forename: S B
authors.initials: SB
authors.lastname: Reffey
authors.forename: A
authors.initials: A
authors.lastname: Frattini
authors.forename: L
authors.initials: L
authors.lastname: Tian
authors.forename: S
authors.initials: S
authors.lastname: Frank
authors.forename: R J
authors.initials: RJ
authors.lastname: Youle
authors.forename: D L
authors.initials: DL
authors.lastname: Nelson
authors.forename: L D
authors.initials: LD
authors.lastname: Notarangelo
authors.forename: P
authors.initials: P
authors.lastname: Vezzoni
authors.forename: H O
authors.initials: HO
authors.lastname: Fearnhead
authors.forename: C S
authors.initials: CS
authors.lastname: Duckett
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D053477:Apoptotic Protease-Activating Factor 1; D015152:Blotting, Northern; D053453:Caspase 9; D061945:Caspase Inhibitors; D020169:Caspases / Q000378:metabolism*; D002460:Cell Line; D003001:Cloning, Molecular; D004791:Enzyme Inhibitors / Q000378:metabolism*; D017930:Genes, Reporter / Q000235:genetics; D006801:Humans; D015151:Immunoblotting; D051034:Inhibitor of Apoptosis Proteins; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics / Q000378:metabolism; D011323:Primates; D011506:Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D016415:Sequence Alignment; D014162:Transfection; D051636:X-Linked Inhibitor of Apoptosis Protein; D051028:bcl-2-Associated X Protein
chemical_list: C506592:APAF1 protein, human; D051017:Apoptosis Regulatory Proteins; D053477:Apoptotic Protease-Activating Factor 1; C494826:BAX protein, human; C430870:BIRC8 protein, human; D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors; C421307:FAIM protein, human; D051034:Inhibitor of Apoptosis Proteins; D011506:Proteins; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D011993:Recombinant Fusion Proteins; D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human; D051028:bcl-2-Associated X Protein; C506433:CASP9 protein, human; D053453:Caspase 9; D020169:Caspases